ASP Isotopes Inc.

ASP Isotopes, Inc.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, ASP Isotopes, Inc. has 130.15M shares outstanding.

As of June 30, 2026, ASP Isotopes, Inc. maintains a current ratio of 3.87, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 98.09, indicating elevated leverage, while an interest coverage ratio of -23.94 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ASP Isotopes, Inc. posted a negative return on equity (ROE) of -91.09, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -37.30, reflecting losses generated across the asset base. The company generates approximately 113,824.23 in revenue per employee across its workforce of 237.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.59 indicates how many times ASP Isotopes, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, ASP Isotopes, Inc. recorded 113,335.59 in income tax expense. The company reported a pretax loss of -119.74M and -115.58M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, ASP Isotopes, Inc. generated 27.00M in revenue and converted that into -115.58M in net income, yielding earnings per share of -1.13. EBITDA reached -81.91M, while operating income came in at -84.34M.

As of June 30, 2026, ASP Isotopes, Inc. holds 223.11M in cash and equivalents against 235.93M in total debt, resulting in a net debt position of 38.10M. Total book value stands at 231.69M, with working capital of 176.71M providing operational flexibility.

ASP Isotopes, Inc. produced -59.35M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -13.81M in capital expenditures, free cash flow totaled -73.15M - equivalent to -0.69 per share.

Over the twelve months ended June 30, 2026, ASP Isotopes, Inc. posted a gross margin of 18.32, reflecting its pricing power and cost economics. The operating margin of -312.31 and net profit margin of -428.00 provide insight into operational efficiency.